title: Patient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefs.
abstract: BACKGROUND
  There are effective treatments to prevent osteoporotic fractures, but these treatments are underutilized.
  
  
  OBJECTIVE
  To evaluate the influence of patient characteristics, perceptions, knowledge and beliefs about osteoporosis on the decision to initiate osteoporotic treatment.
  
  
  METHODS
  We identified female members of a managed care plan who had a dual energy x-ray absorptiometry (DXA) bone density test and fulfilled World Health Organization criteria for osteoporosis. Patients were excluded if they received osteoporotic medications in the prior 6 months.
  
  
  METHODS
  Patients were sent a questionnaire that included items assessing satisfaction with physician-patient communication, trust in the physician, osteoporosis knowledge and beliefs, beliefs about prescription medications, and perceptions of barriers to medication use. Administrative electronic health records were used to identify prescription drug use and health care utilization.
  
  
  RESULTS
  Two hundred and thirty-six women returned surveys and research authorization forms out of 465 contacted for participation. One hundred and thirty-five (57.2%) filled a prescription for an osteoporotic drug in the first 3 months after the DXA exam. The largest differences between initiators and non-initiators were in beliefs in the benefits of medications, and distrust of medications, with initiators believing more strongly in the benefits and effectiveness of medications (p < .001), and non-initiators reporting more distrust of medications (p < .001). Osteoporosis knowledge and the belief that osteoporosis is a serious disease were also related to therapy initiation in bivariate analysis.
  
  
  CONCLUSIONS
  Only 57% of patients initiated osteoporotic medication within 3 months of diagnosis. The decision to start osteoporosis treatment appeared to be related to a patient's beliefs in the effectiveness of osteoporosis medications and distrust of medications.
authors.affiliation: Fallon Clinic, Worcester, MA 01605, USA. robert.yood@fallonclinic.org
authors.forename: Robert A
authors.initials: RA
authors.lastname: Yood
authors.forename: Kathleen M
authors.initials: KM
authors.lastname: Mazor
authors.forename: Susan E
authors.initials: SE
authors.lastname: Andrade
authors.forename: Srinivas
authors.initials: S
authors.lastname: Emani
authors.forename: Wing
authors.initials: W
authors.lastname: Chan
authors.forename: Kristijan H
authors.initials: KH
authors.lastname: Kahler
mesh_terms: D000328:Adult; D000368:Aged; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D015331:Cohort Studies; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006306:Health Surveys; D006801:Humans; D008329:Managed Care Programs; D055118:Medication Adherence; D008875:Middle Aged; D010024:Osteoporosis / Q000188:drug therapy*; D017060:Patient Satisfaction
chemical_list: D050071:Bone Density Conservation Agents
references.citation: Osteoporos Int. 2005 Feb;16(2):115-27
references.pmid: 15517187
references.citation: Mayo Clin Proc. 2006 Aug;81(8):1013-22
references.pmid: 16901023
references.citation: J Chronic Dis. 1987;40(5):373-83
references.pmid: 3558716
references.citation: J Womens Health (Larchmt). 2003 Dec;12(10):1037-45
references.pmid: 14709192
references.citation: Maturitas. 2004 Jul 15;48(3):271-87
references.pmid: 15207894
references.citation: Isr Med Assoc J. 2003 Dec;5(12):859-62
references.pmid: 14689753
references.citation: Arch Intern Med. 2007 Apr 23;167(8):847-52
references.pmid: 17452550
references.citation: Am J Health Syst Pharm. 2003 Apr 1;60(7):657-65
references.pmid: 12701547
references.citation: Lancet. 1996 Aug 10;348(9024):383-6
references.pmid: 8709739
references.citation: Maturitas. 2005 Mar 14;50(3):196-208
references.pmid: 15734601
references.citation: Am J Med. 2003 Aug 15;115(3):209-16
references.pmid: 12947959
references.citation: Int J Cardiol. 2000 Nov-Dec;76(2-3):157-63
references.pmid: 11104870
references.citation: Med Care. 2007 Jun;45(6):521-8
references.pmid: 17515779
references.citation: BMJ. 2002 Oct 19;325(7369):873
references.pmid: 12386041
references.citation: Fam Pract. 1997 Oct;14(5):369-75
references.pmid: 9472370
references.citation: J Clin Epidemiol. 1992 Jun;45(6):613-9
references.pmid: 1607900
references.citation: Res Theory Nurs Pract. 2002 Fall;16(3):179-92
references.pmid: 12472293
references.citation: BMC Health Serv Res. 2005 Oct 03;5:64
references.pmid: 16202125
references.citation: Osteoporos Int. 2003 Dec;14(12):965-8
references.pmid: 14504697
references.citation: Soc Sci Med. 2005 Jul;61(1):133-55
references.pmid: 15847968
references.citation: Curr Med Res Opin. 2006 May;22(5):949-60
references.pmid: 16709316
references.citation: Bone. 2006 Jun;38(6):922-8
references.pmid: 16330270
references.citation: Am J Med. 2004 Jul 15;117(2):130-2
references.pmid: 15234651
references.citation: Bone. 2007 Nov;41(5):882-7
references.pmid: 17707710
references.citation: Arthritis Rheum. 2006 Oct 15;55(5):729-35
references.pmid: 17013870
references.citation: J Clin Pharm Ther. 2001 Oct;26(5):331-42
references.pmid: 11679023
references.citation: Am J Epidemiol. 2007 Aug 1;166(3):348-54
references.pmid: 17504779
references.citation: Osteoporos Int. 2004 Dec;15(12):1003-8
references.pmid: 15167989
references.citation: N Engl J Med. 2005 Aug 4;353(5):487-97
references.pmid: 16079372
references.citation: Osteoporos Int. 2006;17(6):914-21
references.pmid: 16538553
references.citation: Drugs Aging. 2007;24(1):37-55
references.pmid: 17233546
references.citation: Arch Intern Med. 2005 Nov 14;165(20):2414-9
references.pmid: 16287772
references.citation: Am J Med. 2007 Mar;120(3):251-6
references.pmid: 17349448
references.citation: Mayo Clin Proc. 2006 Aug;81(8):1009-12
references.pmid: 16901022